Skip to content
HeyJared

Sam Robinson

Reporter

Indexed articles, last 90 days
106
Latest publication
Oct 1, 2026
Outlet visibility, for Healthcare Digital
Top 5M sites
Earliest in this view
Jul 10, 2026

Latest articles

  1. Article · Oct 1, 2026 · Sam Robinson

    Q&A: AWS’ Sasha Rubel on AI Regulation & European Healthcare (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    Sasha Rubel leads AI Policy across Europe, the Middle East and Africa at Amazon Web Services (AWS). Working with governments to support their understanding of what AI means in practice and helping technology leaders navigate the rules shaping how AI is built and deployed, Sasha is on the frontline of AI policy across the EMEA region. Before joining AWS, Sasha gained deep experience in international affairs, spending over a decade at UNESCO, including positions in Ethiopia and Senegal. Following

  2. Article · Oct 1, 2026 · Sam Robinson

    Novo, Hengrui Agree US$2.6bn Deal For Weekly GLP-1/GIP Pill (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    As the race to lead the GLP-1 market with Eli Lilly intensifies, Novo is expanding its pipeline with a multi-billion-dollar licensing deal with Chinese pharmaceutical leader Hengrui Pharmaceuticals. The exclusive agreement includes $US300m upfront, alongside US$2.3bn in commercial, regulatory and development-related milestone payments. Under the agreement, Novo gains exclusive rights to develop and commercialise HRS-1596, a phase-1-ready once-weekly oral GLP-1/GIP treatment, outside mainland Chi

  3. Article · Sep 30, 2026 · Sam Robinson

    Top 10: Bio-Pharmaceutical Companies (opens the original)

    Excerpt · English

    Read excerpt

    The global biopharmaceutical industry is investing heavily in the next generation of medicines, with thousands of drug candidates progressing through discovery and clinical development. Using data from Citeline’s 2026 Pharma R&D Annual Review, this ranking examines the biopharmaceutical firms with the highest number of drug candidates in development. The analysis highlights the scale of leading companies’ research operations, while also bringing emerging pharmaceutical players into the picture.

  4. Article · Sep 29, 2026 · Sam Robinson

    Fresenius & NHS Partner on UK-First Net-Zero Dialysis Centre (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    From summer 2027, the UK is expected to have an innovative first within its national health infrastructure: a net-zero emissions dialysis centre. Construction has started on the purpose-built 27-station centre at Aintree University Hospital in Liverpool as Fresenius Medical Care and NHS University Hospitals of Liverpool Group collaborate to make the UK’s first net-zero dialysis facility a reality. With capacity for 160 patients, the centre will replace the current Aintree clinic and Waterloo uni

  5. Article · Sep 29, 2026 · Sam Robinson

    GE HealthCare Appoints Rodolphe Katra as Chief AI Officer (opens the original)

    Excerpt · English

    Read excerpt

    GE HealthCare has appointed Rodolphe Katra as its new Global Chief AI Officer, as the medical technology company looks to expand its use of AI across devices, software and healthcare data. Rodolphe joins from Medtronic, where he served as Chief AI Officer for the past three years. Following in the footsteps of GE HealthCare’s former AI chief Parminder Bhatia, who left the company in July 2026, Rodolphe will report to Global Chief Science and Technology Officer Taha Kass-Hout. The appointment com

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

For Healthcare Digital, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Sam Robinson